Costs related to drugs produced by recombinant DNA technology

Am J Health Syst Pharm. 2000 Jan 1;57(1):78-9. doi: 10.1093/ajhp/57.1.78.
No abstract available

Publication types

  • News

MeSH terms

  • Budgets
  • Costs and Cost Analysis
  • France
  • Humans
  • Recombinant Proteins / economics*

Substances

  • Recombinant Proteins